MedTrace Logo

Evaluate the Quality of Life of Patients With AMD

NCT03242083 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 28

Last updated 2020-01-23

No results posted yet for this study

Summary

Age-related macular degeneration (AMD) is a major cause of deep visual acuity loss. Because of progressive deterioration of the macula, patients with AMD complain about progressive visual problems that can impair their quality of life in the physical, mental and social domains. The principal objective principal of this study is to describe the evolution of quality of life between the diagnosis of secondary atrophic AMD and at 18 months after confirmation of diagnosis.

Conditions

  • Age-related Macular Degeneration

Interventions

OTHER

quality of life questionnaire

quality of life questionnaire

Sponsors & Collaborators

  • Centre Hospitalier Universitaire Dijon

    lead OTHER

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-08
Primary Completion
2019-12-03
Completion
2019-12-03

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03242083 on ClinicalTrials.gov